Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats

In recent decades, therapy for acute myeloid leukemia (AML) has remained relatively unchanged, with chemotherapy regimens primarily consisting of an induction regimen based on a daunorubicin and cytarabine backbone, followed by consolidation chemotherapy. Patients who are relapsed or refractory can...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Brent A., Law, Arjun, Hunyadkurti, Judit, Desilets, Stephanie, Leyton, Jeffrey V., Keating, Armand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723634/
https://www.ncbi.nlm.nih.gov/pubmed/31434267
http://dx.doi.org/10.3390/jcm8081261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723634/
https://www.ncbi.nlm.nih.gov/pubmed/31434267
http://dx.doi.org/10.3390/jcm8081261

Ejemplares similares